Squarepoint’s Monte Rosa Therapeutics GLUE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $803K | Buy |
+178,136
| New | +$803K | ﹤0.01% | 1647 |
|
|
2025
Q1 | – | Sell |
-31,654
| Closed | -$220K | – | 2935 |
|
|
2024
Q4 | $220K | Buy |
+31,654
| New | +$220K | ﹤0.01% | 2343 |
|
|
2024
Q3 | – | Sell |
-22,665
| Closed | -$84.8K | – | 2707 |
|
|
2024
Q2 | $84.8K | Buy |
+22,665
| New | +$84.8K | ﹤0.01% | 2289 |
|
|
2024
Q1 | – | Sell |
-17,462
| Closed | -$98.7K | – | 2609 |
|
|
2023
Q4 | $98.7K | Buy |
+17,462
| New | +$98.7K | ﹤0.01% | 2275 |
|
|
2023
Q2 | – | Sell |
-13,998
| Closed | -$109K | – | 2552 |
|
|
2023
Q1 | $109K | Buy |
+13,998
| New | +$109K | ﹤0.01% | 2011 |
|
|
2022
Q4 | – | Sell |
-28,410
| Closed | -$232K | – | 2395 |
|
|
2022
Q3 | $232K | Buy |
28,410
+13,108
| +86% | +$107K | ﹤0.01% | 1740 |
|
|
2022
Q2 | $148K | Buy |
+15,302
| New | +$148K | ﹤0.01% | 1806 |
|
|
2021
Q3 | – | Sell |
-28,209
| Closed | -$640K | – | 2424 |
|
|
2021
Q2 | $640K | Buy |
+28,209
| New | +$640K | ﹤0.01% | 1463 |
|